{
    "title": "Roche gets jump on rivals in race for progressive MS treatment",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3252141/Roche-gets-jump-rivals-race-progressive-MS-treatment.html",
    "date": "2015-09-28",
    "keywords": [
        "drug",
        "roche",
        "ms",
        "trial",
        "race",
        "treatment",
        "gmt",
        "september",
        "email",
        "success",
        "ocrelizumab",
        "market",
        "year",
        "medicine",
        "group",
        "ben",
        "hirschlerlondon",
        "position",
        "sclerosis",
        "number",
        "form",
        "disease",
        "progressive",
        "news",
        "approval",
        "head",
        "development",
        "paulo",
        "fontoura",
        "monday",
        "competitionhowever",
        "sedel",
        "executive",
        "biotech",
        "firm",
        "medday",
        "heelssedel",
        "company",
        "order",
        "md1003",
        "damage",
        "nerve",
        "timing",
        "submission",
        "formulation",
        "food",
        "biotin",
        "phase",
        "francedsm",
        "deal",
        "tablet",
        "contrast",
        "infusionfurther",
        "behind",
        "midstage",
        "study",
        "april",
        "damageand",
        "university",
        "college",
        "london",
        "phenytoin",
        "epilepsy",
        "msin",
        "meantime",
        "advantage",
        "opportunity",
        "remitting",
        "priceroche",
        "price",
        "segment",
        "competition",
        "analyst",
        "tim",
        "anderson",
        "research",
        "noteediting",
        "david"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}